Scholarship to support students from Ukraine, Russia
Blue Ash-based InfoTrust establishes fund to help students affected by war
A Greater Cincinnati company has established a scholarship for international students at the University of Cincinnati affected by the Russian invasion of Ukraine, the Cincinnati Business Courier reported.
InfoTrust, a tech company headquartered in Blue Ash, Ohio, has established the InfoTrust Foundation Scholarship Fund at UC. The scholarship will support students from Ukraine or Russia who have been directly affected by the Russia-Ukraine war.
The company is working in partnership with the UC Foundation for the soon-to-be annual scholarship. A total dollar amount hasn’t been finalized.
InfoTrust’s co-founders are from Ukraine, and a number of InfoTrust team members have relatives in Ukraine and Russia.
“This war is personal to me,” InfoTrust CEO Alex Yastrebenetsky said. “My parents just recently were able to get out of Ukraine themselves, so I want to do everything I can to help others, especially students, who may be in a similar situation.”
More information can be supplied to interested readers upon request.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Everything you need to know about scents and your hair
May 1, 2025
The University of Cincinnati's Kelly Dobos was featured in an NBC News article discussing the science behind hair fragrances and shampoos.
A farewell for the iconic Crosley Tower
May 1, 2025
The Cincinnati Business Courier reports that UC Board of Trustees approved $47.3 million for remediation and demolition of Crosley Tower. There are mixed feelings about what has been dubbed by some as the ugliest building on a U.S. college campus.
Most teens prescribed SSRIs did not have recommended follow-up...
April 30, 2025
The University of Cincinnati and Cincinnati Children's Hospital Medical Center's Martine Lamy commented to Medscape on new research that found fewer than half of the adolescents prescribed a selective serotonin reuptake inhibitor (SSRI) at two large Chicago pediatric primary care clinics had a follow-up visit within the recommended 6 weeks.